0.28
+0.0319(+12.74%)
Currency In USD
| Previous Close | 0.25 |
| Open | 0.26 |
| Day High | 0.28 |
| Day Low | 0.26 |
| 52-Week High | 2.04 |
| 52-Week Low | 0.17 |
| Volume | 1.7M |
| Average Volume | 9.05M |
| Market Cap | 41.36M |
| PE | -1.05 |
| EPS | -0.27 |
| Moving Average 50 Days | 0.36 |
| Moving Average 200 Days | 1.01 |
| Change | 0.03 |
If you invested $1000 in Biodesix, Inc. (BDSX) since IPO date, it would be worth $22.03 as of July 01, 2025 at a share price of $0.282. Whereas If you bought $1000 worth of Biodesix, Inc. (BDSX) shares 3 years ago, it would be worth $172.07 as of July 01, 2025 at a share price of $0.282.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
GlobeNewswire Inc.
Jun 10, 2025 10:17 AM GMT
Nation’s first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programsLOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic s
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
GlobeNewswire Inc.
May 22, 2025 9:03 PM GMT
New data from the INSIGHT study demonstrates the VeriStrat Host Immune Classifier (HIC)’s ability to predict overall survival in patients with non-small cell lung cancer treated with immunotherapyLOUISVILLE, Colo., May 22, 2025 (GLOBE NEWSWIRE) --
Biodesix to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
May 21, 2025 10:00 AM GMT
LOUISVILLE, Colo., May 21, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that members of the Biodesix management team, will participate in two upcoming investor conferences: 22nd Ann